Skip to Content

Indiva Ltd NDVAF

Morningstar Rating
$0.02 −0.01 (19.73%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NDVAF is trading at a 325% premium.
Price
$0.02
Fair Value
$6.48
Uncertainty
Extreme
1-Star Price
$1.18
5-Star Price
$9.93
Economic Moat
Xrtz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NDVAF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.03
Day Range
$0.020.02
52-Week Range
$0.010.09
Bid/Ask
$0.02 / $0.03
Market Cap
$4.10 Mil
Volume/Avg
510,990 / 32,084

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.13
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Indiva Ltd sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, the company produces and distributes award-winning cannabis products nationally, including Bhang Chocolate, Doppio, Cookies, Sour Gummies, Slow Ride Bakery, THC Tablets and Capsules, Ruby Cannabis Sugar and others.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
142

Valuation

Metric
NDVAF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
0.13
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
NDVAF
Quick Ratio
0.41
Current Ratio
0.70
Interest Coverage
0.04
Quick Ratio
NDVAF

Profitability

Metric
NDVAF
Return on Assets (Normalized)
−12.03%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
0.43%
Return on Assets
NDVAF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
LtjcngsyVqdrs$82.1 Bil
Merck KGaA ADR
MKKGY
WlrfjskfjvDjjqqcx$75.2 Bil
Haleon PLC ADR
HLN
RfstdrhbxYyjm$41.4 Bil
Viatris Inc
VTRS
VbcgfmwJhxt$14.4 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
MqgkmjrNpw$13.7 Bil
Catalent Inc
CTLT
QrqsdngwFmfmfs$10.6 Bil
Perrigo Co PLC
PRGO
YvfnpqfrYgw$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
MyjnqlkDdpldrs$3.5 Bil
Curaleaf Holdings Inc
CURLF
DhtjsxybmXfgq$3.0 Bil
Green Thumb Industries Inc
GTBIF
FdvlsbgbdKzfd$2.7 Bil

Sponsor Center